Atlas Trials

BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer

Clinical trial NCT02125175 · COMPLETED

Trial details

NCT number
NCT02125175
Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2014-01-01
Primary completion
2018-09-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.